1. Signaling Pathways
  2. GPCR/G Protein
  3. LPL Receptor
  4. S1PR3 Isoform

S1PR3

 

S1PR3 Related Products (7):

Cat. No. Product Name Effect Purity
  • HY-12355
    Siponimod
    Agonist 98.88%
    Siponimod (BAF-312) is an orally active and selective sphingosine-1-phosphate (S1P) receptor modulator.
  • HY-10569
    Ponesimod
    Agonist 99.81%
    Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay.
  • HY-119401
    CAY10444
    Antagonist ≥98.0%
    CAY10444 (BML-241) is a sphingosine-1-phosphate 3 (S1P3) antagonist.
  • HY-113934
    L-threo Lysosphingomyelin (d18:1)
    Agonist ≥98.0%
    L-threo Lysosphingomyelin (d18:1) (L-threo-Sphingosylphosphorylcholine) is an endogenous bioactive sphingolipid.
  • HY-12355A
    Siponimod hemifumarate
    Agonist
    Siponimod (BAF-312) hemifumarate is a potent and selective sphingosine-1-phosphate (S1P) receptor modulator.
  • HY-111253
    CYM-5478
    Agonist
    CYM-5478 is a potent and highly selective S1P2 agonist with an EC50 of 119 nM in a TGFα-shedding assay.
  • HY-108492
    TC-SP 14
    Agonist
    TC-SP 14 (compound 14) is an orally active and potent S1P1 agonist (EC50 = 0.042 μM) with minimal activity at S1P3 (EC50 = 3.47 μM).